With tirzepatide, patients lose an average of 15-22% of body weight (40-56 pounds for a 250-pound person)
Importantly, surgical truncal vagotomy typically blocks or significantly reduces this retrograde spread, implicating vagal axons in transneuronal transport
, 16 , 1303-1314, doi: Nishizawa, S., Araki, H., Ishikawa, Y., Kitazawa, S., Hata, A., Soga, T., and Hara, T
Semaglutide reduces the desire to overeat, but willpower and emotional regulation remain important tools
Clinical trials demonstrate that tirzepatide typically produces greater weight reduction than semaglutide at equivalent timepoints
This question echoes in the minds of many health enthusiasts, as timing and method can significantly impact the effectiveness of any supplement